Home > Insider Trading > Filing (0001127602-15-016867)

Filing Details

Accession Number:: 0001127602-15-016867
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-11 16:56:21
Reporting Period:: 2015-05-07

Filing Date:: 2015-05-11
Accepted Time:: 2015-05-11 16:56:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318154	Amgen Inc	AMGN	Biological Products, (No Disgnostic Substances) (2836)	953540776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555508	Madhavan Balachandran	One Amgen Center Drive Thousand Oaks CA 91320-1799	Evp, Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-05-07	6,000	$58.43	39,394	No	4	M	Direct
Common Stock	Acquisiton	2015-05-07	15,750	$54.69	55,144	No	4	M	Direct
Common Stock	Disposition	2015-05-07	6,000	$157.92	49,144	No	4	S	Direct
Common Stock	Disposition	2015-05-07	15,750	$157.85	33,394	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nqso (Right to Buy)	Disposition	2015-05-07	6,000	$0.00	6,000	$58.43
Common Stock	Nqso (Right to Buy)	Disposition	2015-05-07	15,750	$0.00	15,750	$54.69

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-04-26	2020-04-26	No	4	M	Direct
0	2013-04-25	2021-04-25	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	56,573	Indirect	By Family Trust

Footnotes

The price reported is an average price. The prices ranged from $157.90 to $157.94 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
The price reported is an average price. The prices ranged from $157.81 to $157.93 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 855 RSUs which vest on 4/27/2016; 17,845 RSUs which vest in one installment of 8,789 on 7/31/2015 and one installment of 9,056 on 7/31/2016; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 4,707 RSUs which vest in two equal installments of 1,553 each on 1/31/2016 and 1/31/2017 and one installment of 1,601 on 1/31/2018; and 3,677 RSUs which vest in two equal installments of 1,213 on 1/30/2017 and 1/30/2018 and one installment of 1,251 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 1,300 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.